Adaptin Bio (APTN) Other Non Operating Income (2024 - 2026)

Adaptin Bio recorded quarterly Other Non Operating Income of $326345.0 in Q1 2026, up 198.1% quarter-over-quarter from -$332657.0 in Q3 2025, and up 5270.23% year-over-year from $6076.9 in Q1 2025.

Adaptin Bio's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $326345.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 5270.23% year-over-year to $326345.0; the TTM figure through Mar 2026 stood at $326345.0 (up 262.59% YoY), while the FY2025 annual figure was -$6312.0, up 96.76% from the prior year.
  • Other Non Operating Income came in at $326345.0 for Q1 2026 at Adaptin Bio, up from -$332657.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $332657.0 in Q2 2025 to a low of -$332657.0 in Q3 2025.
  • A 3-year average of $15687.0 and a median of -$4311.0 in 2024 frame the typical range for Other Non Operating Income.
  • On a YoY basis, Other Non Operating Income climbed as much as 14118.42% in 2025 and fell as far as 5223.36% in 2025.
  • Adaptin Bio's Other Non Operating Income stood at -$185782.0 in 2024, then tumbled by 79.06% to -$332657.0 in 2025, then soared by 198.1% to $326345.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $326345.0, -$332657.0, and $332657.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 326,345.00
Dec 31, 2025 -332,657.00
Mar 31, 2025 326,345.00
Dec 31, 2024 -8,332.00
Sep 30, 2024 -6,249.00
Jun 30, 2024 -2,373.00
Mar 31, 2024 -133.00